Developer docs
API playgroundTry for free, no card

Search company profiles

InnAccel

Full company profile

uuid0003p3l

Namestring
InnAccel
Legal namestring
InnAccel Technologies Private Limited
Websiteurl
innaccel.com
Company typeenum
Private
Founded yearint
2014
Descriptiontext

InnAccel Technologies Private Limited is a Bangalore-based medical device company founded in 2014 that designs, develops, and commercializes patented medical technologies for critical care, neonatology, and maternal health, with an explicit focus on resource-limited emerging markets. Its portfolio spans three product platforms: VapCare, an automated secretion management and oral hygiene system for ventilated ICU patients designed to reduce ventilator-associated pneumonia; Fetal Lite, an AI-powered wireless fetal heart rate monitor using fetal ECG/EMG signal extraction for intrapartum care; and SAANS, a portable, infrastructure-independent multi-therapy neonatal breathing support system offering Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes in a single device with battery backup. These platforms are built on a Product Engineering and Development (PED) methodology that originated in clinical immersion and needs identification in partner hospitals.

The business operates a hybrid commercialization model combining direct enterprise sales (field Application Specialists in Bangalore, New Delhi, and Patna conducting hospital demonstrations, installations, and training) with public-sector and donor-funded deployments. Notable deployments include 300+ SAANS devices across 30+ government hospitals in Assam (funded by USAID and the Bill & Melinda Gates Foundation in partnership with C-CAMP), an IFC-funded deployment at Hallelujah General Hospital in Ethiopia, and a NARAYANA Health Bangalore clinical trial for VapCare. Direct revenue from medical device sales (hardware) is supplemented by research grants from BIRAC, the Millennium Alliance, the Lemelson Foundation, and other donors, plus pricing is quote-based rather than publicly disclosed. Multi-jurisdictional regulatory clearance is significant: Indian CDSCO across all three core products, U.S. FDA and EU CE for VapCare, EU CE and Indian CDSCO for Fetal Lite, and USFDA 510(k) clearance for SAANS secured in January 2026.

Customer concentration is split across state-level public health systems, international donor agencies, NGOs (I-DO, Infosys Foundation, American India Foundation, ACT), and a long tail of more than 300 hospitals in India and abroad. The company maintains a relatively small team (11–50 employees) backed by an institutional roster including Siraj Dhannani (CEO, ex-PharmARC/IQVIA), A. Vijayrajan (CTO, ex-GE Medical Systems, Wipro Health Sciences, HP), and Shaunak Patel (CCO, ex-J&J Medical India, L.E.K.). Awards include Modi Prix Galien India 2025, Bengaluru Tech Summit Innovator of the Year 2025, MIT Solve Global Health Equity Winner 2024, Gates Foundation recognition, WHO Compendium inclusion 2022, and CES Global Women's HealthTech Award 2021.

Short descriptiontext

InnAccel is a Bangalore-based medical technology company developing patented critical care, neonatal, and maternal health devices (VapCare, Fetal Lite, SAANS) for hospitals and government health systems in India and other emerging markets, combining direct sales with grant-backed and donor-funded large-scale deployments.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical devices, neonatal respiratory care, fetal monitoring, critical care equipment, maternal health technology
Industry3 codes
PRIMARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
NAICS code2 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Devices
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Sales
TypeHardware Sales
Description

Sale of medical devices including VapCare, Fetal Lite, and Saans to hospitals, healthcare institutions, and public health systems. Products sold directly to healthcare providers with installation, training, and technical support services.

innaccel.com
2Public Health System Deployments
TypeHardware Sales
Description

Large-scale deployments funded by government health departments, international donors (USAID, Gates Foundation), and CSR programs. State-level implementations in Assam and Rajasthan represent significant revenue streams.

innaccel.com
3Research Grants and Funding
TypeLicensing Royalties
Description

Grant funding from organizations including BIRAC Product Commercialization Program, Millennium Alliance, Lemelson Foundation, and international donors for R&D and deployment projects.

innaccel.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1No public pricing available
ModelOtherBilling cadenceOther
Notes

Quote-based / Not publicly disclosed. Sales process involves direct engagement with sales team for product demonstrations and custom pricing.

innaccel.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1VapCare
Description

Automated and intelligent secretion management and oral hygiene system for ventilated ICU patients. First-in-the-world automated system addressing Ventilator Associated Pneumonia (VAP).

innaccel.com
+2 more records
Core offering1 text field

InnAccel designs, develops, manufactures, and commercializes patented medical devices for critical care, obstetrics, and neonatal/pediatric care in emerging markets. Its core product portfolio comprises VapCare (automated secretion/oral hygiene management for ventilated ICU patients), Fetal Lite (AI-powered fetal heart rate monitor using ECG signal extraction), and SAANS (multi-therapy, infrastructure-independent neonatal breathing support device with Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes). The company sells directly to hospitals, public health systems, NGOs, and international organizations, and supports deployments with installation, training, and ongoing technical service.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 82% success rate in IFC-funded Saans deployment at Hallelujah General Hospital, Addis Ababa, avoiding invasive mechanical ventilation
+4 more records
Product overview1 text field

InnAccel is a medical device company offering a portfolio of three core patented technologies addressing critical unmet needs in healthcare. VapCare provides automated oral hygiene management for ventilated ICU patients to prevent ventilator-associated pneumonia. Fetal Lite offers AI-powered wireless fetal monitoring using ECG signal extraction technology for mothers during labor. SAANS delivers multi-therapy breathing support (Bubble CPAP, nasal CPAP, HFNC, resuscitation) for neonates and pediatric patients in a single portable device. The product ecosystem spans critical care, maternal health, and neonatal care, with all products designed for accessibility in resource-limited settings.

Product and service3 records
1VapCare
CategoryCritical Care Medical Device
Description

First-in-the-world automated secretion management and oral hygiene system for ventilated ICU patients. Automates airway suctioning and oral lavage to ensure consistent compliance with infection prevention protocols, reducing Ventilator-Associated Pneumonia (VAP) risk. For hospital ICUs and critical care providers.

2Fetal Lite
CategoryObstetrics Medical Device
Description

AI-powered wireless fetal monitoring system based on fetal ECG signal extraction technology. Designed for mothers in labor or post 36 weeks of gestation, measures fetal heart rate, maternal heart rate, and uterine activity with AI-driven risk classification for fetal distress. For obstetricians, labor and delivery wards, and antenatal care units.

3SAANS
CategoryNeonatal and Pediatric Medical Device
Description

Intelligent, infrastructure-independent, multi-therapy breathing support system for neonatal and pediatric patients. Provides Bubble CPAP, nasal CPAP, HFNC therapy, and resuscitation in a single portable device with in-built air-oxygen blender, sensors for flow/pressure/FiO2 monitoring, and 6-hour battery backup. USFDA 510(k) cleared. For NICUs, PICUs, labor rooms, stabilization units, and transport settings.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership with Infosys Foundation and C-CAMP on Project Early Life, aimed at improving healthcare for expectant mothers and newborns across Karnataka.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Saans acknowledged by UNITAID (WHO-hosted organization) in connection with its potential to address neonatal respiratory distress in low-resource settings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

Collaboration on Project SAANS Assam, a state-wide deployment of 300+ Saans devices across 30+ hospitals covering all NICUs in Assam's State Government health system. Funded by USAID and Bill & Melinda Gates Foundation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

NGO partnership for Fetal Lite deployment in Mobile Medical Units serving tribal populations in Kothagudem district, Telangana/Chhattisgarh border area. Covers 2300 tribal members in 18 villages.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-01-01
Description

IFC-funded Saans deployment at Hallelujah General Hospital in Addis Ababa, Ethiopia showing 82% success rate in clinical outcomes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

New Zealand-based global leader in respiratory care, including neonatal CPAP, HFNC, and humidification systems. Directly competes with SAANS in the neonatal respiratory support category, with established hospital distribution and significant R&D resources.

TypeRegional player
Description

India-based manufacturer of neonatal and maternal care equipment including phototherapy, warmers, and CPAP. Comparable to InnAccel in serving Indian hospital customers with neonatal devices, with overlapping product categories and distribution channels.

3Dräger
TypeBroad incumbent
Description

German medical technology company with a strong neonatal and respiratory care portfolio, including Babylog CPAP and ventilation systems. Competes with SAANS in the neonatal respiratory support category, and with VapCare in the ICU ventilation accessories space.

TypeBroad incumbent
Description

Global medtech incumbent with the Avalon fetal/maternal monitor product line, a primary competitor to Fetal Lite in obstetrics. Has broad distribution and clinical relationships in Indian and emerging market hospitals where InnAccel also sells.

5Monica Healthcare
TypeDirect peer
Description

UK-based company specializing in fetal ECG monitoring technology (acquired by GE). Most direct technology peer to Fetal Lite, as both use fetal ECG signal extraction for fetal heart rate monitoring, validating the technical approach.

TypeEmerging player
Description

China-based global medical device company with growing presence in patient monitoring, neonatal care, and emerging markets. Competes with InnAccel in low-cost emerging market segments with broader product portfolios and aggressive pricing.

TypeBroad incumbent
Description

Global medtech leader in fetal monitoring (Corometrics), maternal care, and patient monitoring. InnAccel's CTO A. Vijayrajan is a former GE Medical Systems executive, and the company competes with GE in fetal and ICU monitoring categories.

TypeDirect peer
Description

US/Kenya-based startup developing wearable vital signs monitors for newborns in resource-limited hospitals. Comparable to InnAccel in developing affordable, infrastructure-independent neonatal monitoring devices for emerging markets with grant-funded deployment models.

TypeDirect peer
Description

India-based medical device startup that developed a continuous temperature monitoring bracelet for newborns to detect hypothermia. Comparable to InnAccel in being a Bangalore-based, impact-focused neonatal device company addressing high-mortality conditions in low-resource settings.

TypeDirect peer
Description

India/US-based social enterprise that developed the Embrace infant warmer for emerging markets, addressing neonatal hypothermia. Highly comparable to InnAccel as a mission-driven, emerging-market-focused neonatal medical device innovator with similar GTM and impact-funder profile.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InnAccel

Medical Devicesinnaccel.com

InnAccel is a Bangalore-based medical technology company developing patented critical care, neonatal, and maternal health devices (VapCare, Fetal Lite, SAANS) for hospitals and government health systems in India and other emerging markets, combining direct sales with grant-backed and donor-funded large-scale deployments.

What InnAccel does

InnAccel Technologies Private Limited is a Bangalore-based medical device company founded in 2014 that designs, develops, and commercializes patented medical technologies for critical care, neonatology, and maternal health, with an explicit focus on resource-limited emerging markets. Its portfolio spans three product platforms: VapCare, an automated secretion management and oral hygiene system for ventilated ICU patients designed to reduce ventilator-associated pneumonia; Fetal Lite, an AI-powered wireless fetal heart rate monitor using fetal ECG/EMG signal extraction for intrapartum care; and SAANS, a portable, infrastructure-independent multi-therapy neonatal breathing support system offering Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes in a single device with battery backup. These platforms are built on a Product Engineering and Development (PED) methodology that originated in clinical immersion and needs identification in partner hospitals.

The business operates a hybrid commercialization model combining direct enterprise sales (field Application Specialists in Bangalore, New Delhi, and Patna conducting hospital demonstrations, installations, and training) with public-sector and donor-funded deployments. Notable deployments include 300+ SAANS devices across 30+ government hospitals in Assam (funded by USAID and the Bill & Melinda Gates Foundation in partnership with C-CAMP), an IFC-funded deployment at Hallelujah General Hospital in Ethiopia, and a NARAYANA Health Bangalore clinical trial for VapCare. Direct revenue from medical device sales (hardware) is supplemented by research grants from BIRAC, the Millennium Alliance, the Lemelson Foundation, and other donors, plus pricing is quote-based rather than publicly disclosed. Multi-jurisdictional regulatory clearance is significant: Indian CDSCO across all three core products, U.S. FDA and EU CE for VapCare, EU CE and Indian CDSCO for Fetal Lite, and USFDA 510(k) clearance for SAANS secured in January 2026.

Customer concentration is split across state-level public health systems, international donor agencies, NGOs (I-DO, Infosys Foundation, American India Foundation, ACT), and a long tail of more than 300 hospitals in India and abroad. The company maintains a relatively small team (11–50 employees) backed by an institutional roster including Siraj Dhannani (CEO, ex-PharmARC/IQVIA), A. Vijayrajan (CTO, ex-GE Medical Systems, Wipro Health Sciences, HP), and Shaunak Patel (CCO, ex-J&J Medical India, L.E.K.). Awards include Modi Prix Galien India 2025, Bengaluru Tech Summit Innovator of the Year 2025, MIT Solve Global Health Equity Winner 2024, Gates Foundation recognition, WHO Compendium inclusion 2022, and CES Global Women's HealthTech Award 2021.

InnAccel firmographics

Firmographics
Name
InnAccel
Legal name
InnAccel Technologies Private Limited
Website
https://innaccel.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
51–100 employees
Short description
InnAccel is a Bangalore-based medical technology company developing patented critical care, neonatal, and maternal health devices (VapCare, Fetal Lite, SAANS) for hospitals and government health systems in India and other emerging markets, combining direct sales with grant-backed and donor-funded large-scale deployments.
Ownership category
akta.pro rank

InnAccel industry classification

Industry
Product category
Medical Devices
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAF
Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHAGAD
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Medical devices
  • Neonatal respiratory care
  • Fetal monitoring
  • Critical care equipment
  • Maternal health technology

Where InnAccel is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices1 record

Markets served

InnAccel business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Medical Device Sales: Sale of medical devices including VapCare, Fetal Lite, and Saans to hospitals, healthcare institutions, and public health systems. Products sold directly to healthcare providers with installation, training, and technical support services.
  2. Public Health System Deployments: Large-scale deployments funded by government health departments, international donors (USAID, Gates Foundation), and CSR programs. State-level implementations in Assam and Rajasthan represent significant revenue streams.
  3. Research Grants and Funding: Grant funding from organizations including BIRAC Product Commercialization Program, Millennium Alliance, Lemelson Foundation, and international donors for R&D and deployment projects.

Pricing tiers

ModelBillingPrice
OtherOtherNo public pricing available

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

InnAccel product offering

Product offering

Core offering

InnAccel designs, develops, manufactures, and commercializes patented medical devices for critical care, obstetrics, and neonatal/pediatric care in emerging markets. Its core product portfolio comprises VapCare (automated secretion/oral hygiene management for ventilated ICU patients), Fetal Lite (AI-powered fetal heart rate monitor using ECG signal extraction), and SAANS (multi-therapy, infrastructure-independent neonatal breathing support device with Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes). The company sells directly to hospitals, public health systems, NGOs, and international organizations, and supports deployments with installation, training, and ongoing technical service.

Product overview

InnAccel is a medical device company offering a portfolio of three core patented technologies addressing critical unmet needs in healthcare. VapCare provides automated oral hygiene management for ventilated ICU patients to prevent ventilator-associated pneumonia. Fetal Lite offers AI-powered wireless fetal monitoring using ECG signal extraction technology for mothers during labor. SAANS delivers multi-therapy breathing support (Bubble CPAP, nasal CPAP, HFNC, resuscitation) for neonates and pediatric patients in a single portable device. The product ecosystem spans critical care, maternal health, and neonatal care, with all products designed for accessibility in resource-limited settings.

Differentiator

Problem solved

Functional benefit

Brands

  • VapCare: Automated and intelligent secretion management and oral hygiene system for ventilated ICU patients. First-in-the-world automated system addressing Ventilator Associated Pneumonia (VAP).
  • Fetal Lite
  • SAANS

Products and services

  • VapCare First-in-the-world automated secretion management and oral hygiene system for ventilated ICU patients. Automates airway suctioning and oral lavage to ensure consistent compliance with infection prevention protocols, reducing Ventilator-Associated Pneumonia (VAP) risk. For hospital ICUs and critical care providers.
  • Fetal Lite AI-powered wireless fetal monitoring system based on fetal ECG signal extraction technology. Designed for mothers in labor or post 36 weeks of gestation, measures fetal heart rate, maternal heart rate, and uterine activity with AI-driven risk classification for fetal distress. For obstetricians, labor and delivery wards, and antenatal care units.
  • SAANS Intelligent, infrastructure-independent, multi-therapy breathing support system for neonatal and pediatric patients. Provides Bubble CPAP, nasal CPAP, HFNC therapy, and resuscitation in a single portable device with in-built air-oxygen blender, sensors for flow/pressure/FiO2 monitoring, and 6-hour battery backup. USFDA 510(k) cleared. For NICUs, PICUs, labor rooms, stabilization units, and transport settings.

Quantifiable outcome

  • 82% success rate in IFC-funded Saans deployment at Hallelujah General Hospital, Addis Ababa, avoiding invasive mechanical ventilation
  • +4 more outcomes

Companies that use InnAccel

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

InnAccel technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

InnAccel partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core and minor.

  • Infosys FoundationcoreStrategic or Co-development Partner · 1 January 2024Partnership with Infosys Foundation and C-CAMP on Project Early Life, aimed at improving healthcare for expectant mothers and newborns across Karnataka.
  • UNITAID / World Health OrganizationminorStrategic or Co-development Partner · 1 January 2023Saans acknowledged by UNITAID (WHO-hosted organization) in connection with its potential to address neonatal respiratory distress in low-resource settings.
  • C-CAMP (Centre for Cellular and Molecular Platforms)coreStrategic or Co-development Partner · 1 January 2022Collaboration on Project SAANS Assam, a state-wide deployment of 300+ Saans devices across 30+ hospitals covering all NICUs in Assam's State Government health system. Funded by USAID and Bill & Melinda Gates Foundation.
  • Indigenous Development Organization (I-DO)coreStrategic or Co-development Partner · 1 January 2022NGO partnership for Fetal Lite deployment in Mobile Medical Units serving tribal populations in Kothagudem district, Telangana/Chhattisgarh border area. Covers 2300 tribal members in 18 villages.
  • International Finance Corporation (World Bank Group)coreStrategic or Co-development Partner · 1 January 2020IFC-funded Saans deployment at Hallelujah General Hospital in Addis Ababa, Ethiopia showing 82% success rate in clinical outcomes.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

InnAccel competitors and assessment

Company assessment

Broad incumbents

  • Fisher & Paykel Healthcare: New Zealand-based global leader in respiratory care, including neonatal CPAP, HFNC, and humidification systems. Directly competes with SAANS in the neonatal respiratory support category, with established hospital distribution and significant R&D resources.
  • Dräger: German medical technology company with a strong neonatal and respiratory care portfolio, including Babylog CPAP and ventilation systems. Competes with SAANS in the neonatal respiratory support category, and with VapCare in the ICU ventilation accessories space.
  • Philips: Global medtech incumbent with the Avalon fetal/maternal monitor product line, a primary competitor to Fetal Lite in obstetrics. Has broad distribution and clinical relationships in Indian and emerging market hospitals where InnAccel also sells.
  • GE HealthCare: Global medtech leader in fetal monitoring (Corometrics), maternal care, and patient monitoring. InnAccel's CTO A. Vijayrajan is a former GE Medical Systems executive, and the company competes with GE in fetal and ICU monitoring categories.

Regional players

  • Phoenix Medical Systems: India-based manufacturer of neonatal and maternal care equipment including phototherapy, warmers, and CPAP. Comparable to InnAccel in serving Indian hospital customers with neonatal devices, with overlapping product categories and distribution channels.

Direct peers

  • Monica Healthcare: UK-based company specializing in fetal ECG monitoring technology (acquired by GE). Most direct technology peer to Fetal Lite, as both use fetal ECG signal extraction for fetal heart rate monitoring, validating the technical approach.
  • Neopenda: US/Kenya-based startup developing wearable vital signs monitors for newborns in resource-limited hospitals. Comparable to InnAccel in developing affordable, infrastructure-independent neonatal monitoring devices for emerging markets with grant-funded deployment models.
  • Bempu Health: India-based medical device startup that developed a continuous temperature monitoring bracelet for newborns to detect hypothermia. Comparable to InnAccel in being a Bangalore-based, impact-focused neonatal device company addressing high-mortality conditions in low-resource settings.
  • Embrace Innovations: India/US-based social enterprise that developed the Embrace infant warmer for emerging markets, addressing neonatal hypothermia. Highly comparable to InnAccel as a mission-driven, emerging-market-focused neonatal medical device innovator with similar GTM and impact-funder profile.

Emerging players

  • Mindray: China-based global medical device company with growing presence in patient monitoring, neonatal care, and emerging markets. Competes with InnAccel in low-cost emerging market segments with broader product portfolios and aggressive pricing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

InnAccel social profiles

Digital presence

InnAccel compliance and trust

Trust signal

Compliance7 records

InnAccel financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InnAccel leadership team

Management profile

Number of profiles

Profiles8 records

InnAccel funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InnAccel M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InnAccel

What does InnAccel do?

InnAccel designs, develops, manufactures, and commercializes patented medical devices for critical care, obstetrics, and neonatal/pediatric care in emerging markets. Its core product portfolio comprises VapCare (automated secretion/oral hygiene management for ventilated ICU patients), Fetal Lite (AI-powered fetal heart rate monitor using ECG signal extraction), and SAANS (multi-therapy, infrastructure-independent neonatal breathing support device with Bubble CPAP, nasal CPAP, HFNC, and resuscitation modes). The company sells directly to hospitals, public health systems, NGOs, and international organizations, and supports deployments with installation, training, and ongoing technical service.

Is InnAccel a public or private company?

InnAccel is a private company. It is classified as venture growth investor backed and is currently operating.

When was InnAccel founded?

InnAccel was founded in 2014. It employs 51 to 100 people.

Where is InnAccel based?

InnAccel is headquartered in Bangalore, India, in the Asia region.

How does InnAccel make money?

Three revenue lines are on record. Medical Device Sales are the primary driver. The others are public Health System Deployments and research Grants and Funding.

Who are InnAccel's main competitors?

Broad incumbents on record are Fisher & Paykel Healthcare, Dräger, Philips and GE HealthCare. Phoenix Medical Systems is listed as a regional player. Direct peers are Monica Healthcare, Neopenda, Bempu Health and Embrace Innovations. Mindray is listed as an emerging player.

Does InnAccel have an API?

No public API is recorded for InnAccel.

What industry is InnAccel in?

InnAccel's product category is Medical Devices. Its primary akta.pro industry code is HLAHACAF, Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables), with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals